Table 1. Age standardised incidence rates of oropharyngeal and oral cavity cancers in Australiaa.
Potentially HPV-associated cancers
|
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Tonsil
b
|
Base of tongue and lingual tonsil
c
|
Other oropharynx
d
|
Comparison cancers
e
|
|||||||||
Time | Count (%) | Rate f | 95% CI | Count (%) | Rate | 95% CI | Count (%) | Rate | 95% CI | Count (%) | Rate | 95% CI |
1982–2005 | ||||||||||||
Total | 3898 (100) | 0.98 | 0.95–1.01 | 2610 (100) | 0.66 | 0.63–0.68 | 2336 (100) | 0.58 | 0.56–0.61 | 28 379 (100) | 7.12 | 7.04–7.21 |
Females | 925 (23.7) | 0.45 | 0.42–0.48 | 623 (23.9) | 0.30 | 0.27–0.32 | 493 (21.1) | 0.23 | 0.21–0.25 | 6591 (23.2) | 3.11 | 3.03–3.18 |
Males | 2973 (76.3) | 1.54 | 1.49–1.60 | 1987 (76.1) | 1.04 | 0.99–1.08 | 1843 (78.9) | 0.97 | 0.92–1.01 | 21 788 (76.8) | 11.58 | 11.42–11.73 |
2000–2005 | ||||||||||||
Total | 1315 (100) | 1.09 | 1.03–1.15 | 954 (100) | 0.79 | 0.74–0.84 | 661 (100) | 0.55 | 0.50–0.59 | 7453 (100) | 6.17 | 6.03–6.31 |
Females | 282 (21.4) | 0.46 | 0.40–0.51 | 227 (23.8) | 0.36 | 0.31–0.41 | 128 (19.3) | 0.20 | 0.16–0.23 | 1866 (25.0) | 2.89 | 2.76–3.03 |
Males | 1033 (78.6) | 1.74 | 1.64–1.85 | 727 (76.2) | 1.23 | 1.14–1.32 | 533 (80.6) | 0.91 | 0.84–0.99 | 5587 (75.0) | 9.75 | 9.5–10.01 |
1994–1999 | ||||||||||||
Total | 993 (100) | 0.95 | 0.89–1.01 | 786 (100) | 0.75 | 0.70–0.80 | 650 (100) | 0.62 | 0.57–0.67 | 7296 (100) | 6.99 | 6.83–7.15 |
Females | 236 (23.8) | 0.44 | 0.38–0.49 | 190 (24.2) | 0.35 | 0.30–0.39 | 149 (22.9) | 0.27 | 0.22–0.31 | 1803 (24.7) | 3.23 | 3.08–3.38 |
Males | 757 (76.2) | 1.50 | 1.39–1.61 | 596 (75.8) | 1.19 | 1.09–1.28 | 501 (77.1) | 1.02 | 0.93–1.11 | 5493 (75.3) | 11.16 | 10.86–11.45 |
1988–1993 | ||||||||||||
Total | 833 (100) | 0.90 | 0.84–0.97 | 518 (100) | 0.57 | 0.52–0.62 | 558 (100) | 0.60 | 0.55–0.65 | 7114 (100) | 7.70 | 7.52–7.88 |
Females | 202 (24.3) | 0.42 | 0.36–0.48 | 128 (24.7) | 0.26 | 0.22–0.31 | 122 (21.9) | 0.24 | 0.20–0.29 | 1559 (21.9) | 3.18 | 3.02–3.33 |
Males | 631 (75.7) | 1.42 | 1.31–1.54 | 390 (75.3) | 0.90 | 0.80–0.99 | 436 (78.1) | 0.98 | 0.88–1.07 | 5555 (78.1) | 12.72 | 12.37–13.06 |
1982–1987 | ||||||||||||
Total | 757 (100) | 0.92 | 0.85–0.98 | 352 (100) | 0.43 | 0.39–0.48 | 467 (100) | 0.57 | 0.52–0.62 | 6516 (100) | 8.02 | 7.82–8.22 |
Females | 205 (27.1) | 0.48 | 0.41–0.55 | 78 (22.2) | 0.18 | 0.14–0.22 | 94 (20.1) | 0.22 | 0.17–0.26 | 1363 (20.9) | 3.17 | 3.00–3.34 |
Males | 552 (72.9) | 1.41 | 1.29–1.53 | 274 (77.8) | 0.71 | 0.62–0.79 | 373 (79.9) | 0.97 | 0.86–1.07 | 5153 (79.1) | 13.50 | 13.11–13.86 |
Abbreviations: CI=confidence interval; HPV=human papillomavirus.
Squamous cell carcinomas.
Tonsil (including Waldeyer's ring) – C09.0, C09.1, C09.8, C09.9 and C14.2.
Base of tongue and lingual tonsil – C01.9 and C02.4.
Other oropharynx – C02.8, C10.2, C10.8, C10.9, C14.0 and C14.8.
Comparison cancers (Ryerson et al, 2008) –
(a) Oral tongue – C02.0, C02.1, C02.2, C02.3 and C02.9.
(b) Other oral cavity sites – C03.0, C03.1, C03.9, C04.0, C04.1, C04.8, C04.9, C05.0, C06.0, C06.1, C06.2, C06.8 and C06.9.
(c) Larynx – C32.0, C32.1, C32.2, C32.3, C32.8 and C32.9.
(d) Other oropharynx sites – C05.1, C05.2, C05.8, C05.9, C10.0, C10.1 and C10.3.
Rates are per 100 000 population and are age standardised to the 2001 Australian population (5 year age groups). (Australian Bureau of Statistics, 2008.)